您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。 [港股财报]:堃博医疗-B中期报告2025 - 发现报告

堃博医疗-B中期报告2025

2025-09-25 港股财报 HEE
报告封面

堃博醫療控股有限公司Broncus Holding Corporation (於開曼群島註冊成立的有限公司)股份代號: 2216 中 期 報 告2025 24592842434446474966 醫療 (ACGHKACG David Scott Lim 97927 David Scott Lim David Scott Lim 15434301-10 1831717121716 PO Box 309, Ugland HouseGrand Cayman, KY1-1104Cayman Islands 8888801 2216 50211101-4 www.broncus.com 24840 +86 0571-8659 5016+86 0571-8796 9085IR@broncuschina.com Maples Fund Services (Cayman) LimitedPO Box 1093, Boundary HallCricket Square, Grand CaymanKY1-1102, Cayman Islands • BroncAblate®®BroncAblate®®(NMPA)BroncAblate®®20253010767BroncAblate®®20253011204 BroncAblate®®BRONC-RFII1RespirologyBroncAblate®® 20257BroncAblate®® • InterVapor®TLD •InterVapor®2025630200InterVapor®500 •InterVapor®30InterVapor® •BTVAInterVapor® •TLD2025630109 • •20253BroncQCT®BroncQCT®CT •LungPro®®BroncTru®®ATVFleXNeedle®(EBUS-GS-TBLB)(EBUS-TTCB)(EBUS-TBNB)LungPro®醫療 • •2025491(2025CMEF)醫療 •2025520254 •20256OCTS 2025 • •20257BroncAblate®®BroncAblate®® •20257BroncAblate®®InterVapor® • •20253醫療LungPro®ArchimedesBroncAblate®®(5th International Sublobar Conference and Bronchoscopic Ablation Summit)醫療(Prof. Calvin S.H. Ng)醫療BroncAblate®® •20254LungPro®Dr. Nicola FacciolongoDr. Roberto Piro •20255BroncAblate®®(3rdGlobal Congress on Robotic Bronchoscopy and CompanionTechnologies)Dr. Kelvin Lau(Prof.Calvin S.H.Ng)醫療BroncAblate®®BroncAblate®® •202563069CE4FDA758 2025630InterVapor®BroncAblate®®TLD (IARC)2022202225012.4%180(18.7%)202210622%203044.5% stereotacticradiotherapySRT BroncAblate®® BroncAblate®® BroncAblate®® BroncAblate®®BroncAblate®®BroncAblate®®LungPro®LungPro®CT BroncAblate®®BRONC-RFII16126BRONC-RFIIRespirology99.35%190.48%196.83%100%3.97% 2025418BroncAblate®®NMPA20253010767623BroncAblate®®NMPA20253011204 BroncAblate®®20258BroncAblate®®9 BroncAblate®® 13 InterVapor®TLDInterVapor®CENMPATLD InterVapor® InterVapor®InterVapor®(BTVA) BTVABTVAInterVapor®2019(FDA)Breakthrough DeviceBTVAGOLD2025 InterVapor®CENMPAInterVapor®2025630InterVapor®50030 InterVapor®30InterVapor® (TLD) TLD TLD20232018920256302020257122026 ® ®® ®2025630RICU 66LungPro®®5LungPro®®LungPro® 30 BroncTru®® BroncTru®®BroncTru®®X BTPNABroncTru®®BTPNA 20239(TBNA) LungPro®BroncTru®®(EBUS-GS-TBLB)LungPro®BroncTru®® BroncTru®®BroncTru®®(EBUS-TTCB) BroncTru®® 30 LungPointLungPoint Plus/Archimedes Lite LungPro/Archimedes LungPointLungPoint PlusArchimedes LiteLungProArchimedes •LungPointLungPoint(VBN)LungPoint2009FDA2011BSI2014 •LungPoint Plus/Archimedes Lite2020CTLungPoint Plus202020213 •LungProArchimedesLungPro/ArchimedesLungPointVBNArchimedesVBNArchimedes2014FDA2014BSI2017 (LungPro) Fibernova BroncQCT® 20253BroncQCT®BroncQCT®CTBroncQCT®醫療CT BroncQCT®CTBroncQCT®InterVapor®BroncAblate®® BroncQCT® TLD InterVapor®FlexNeedleATVInterVapor®3,122863ISO13485 InterVapor® ISO13485NMPAGMPFDAOSRMDR 2025630醫療 102020BroncAblate®®InterVapor®TLD BroncAblate®® InterVapor®InterVapor®2025630200InterVapor®500 BroncAblate®®(5thInternational Sublobar Conference and Bronchoscopic Ablation Summit)(3rd Global Congress on Robotic Bronchoscopy and Companion Technologies)BroncAblate®®CE • InterVapor®302025630810InterVapor® • 20257BroncAblate®®95BroncTru®®® InterVapor® 20253InterVapor®BTVABroncAblate®®20257716718InterVapor®BTVA 202563069CE 4FDA 758 1.720246300.1 1.73.755.4%InterVapor®InterVapor®BroncAblate®®(NMPA) 0.40.841.6% 1.23.058.9%202563073.5%79.8% 4.51.1 3.30.411.9% CRO 202520246304.56.531.4% 3.60.01 2025630130.820241231139.38.51.615% 2025630 30,000202430,0007,467202422,00025,000202425,000 20256300.03%202412310.19% 2025630 2025630238,00020241231238,00050,882,558.79 (1) (2) 2024 202563015 202563019317122 6.0120247.86 35%14%15 27%8% 5% 13.51B(1)2024123113.51(2)(a)(e)(g) 2025514GSFGSF 13.51B(1) 2025630XV(a)XV78(b)352(c) (1)2025630528,088,944(2)1,505,9122025630(3)2024121626,359,904202563010,543,961(4)2025630Wise Seed Limited36.63%Wise Seed Limited2,999,396Wise Seed Limited 2025630XVXV78352 2025630XVXV23336 (1)2025630528,088,944 (2)Qiming Venture Partners IV, L.P.QM12 96.94%Qiming GP IV, L.P.Qiming Venture Partners IV, L.P.Qiming Corporate GP IV, LtdQiming GP IV, L.P.QM12 (3)Xin Nuo Tong Investment LimitedXin Nuo Tong Investment LimitedDinova Capital LimitedDinova Capital LimitedDinova Venture Partners GP III, L.P.Dinova Venture Partners GPIII, L.P.Dinova Healthcare Gamma Fund (USD) L.P.Dinova Healthcare Gamma Fund (USD) L.P.BroncusBiomedical Limited2025630XinNuo TongInvestment LimitedBroncus Biomedical Limited20,558,749Dinova Venture Partners GP III,L.P.3,460,008Xin Nuo Tong Investment Limited9,286,391 (4)Xin Nuo Tong Investment LimitedDinova Venture Capital Limited 70%Dinova Venture Capital LimitedDinova Venture Partners GP IV L.P.Dinova Venture Partners GP IV L.P.Dinova HealthcareDelta Fund (USD) L.P.2025630Xin Nuo Tong InvestmentLimitedDinova Venture Partners GP IV L.P.1,636,068Dinova Healthcare Delta Fund (USD)L.P.6,044,883 (5)40% (6)2025630DinovaVenture Partners Limited